Science news and articles on health, environment, global warming, stem cells, bird flu, autism, nanotechnology, dinosaurs, evolution -- the latest discoveries in astronomy, anthropology, biology, chemistry, climate & bioengineering, computers, engineering ; medicine, math, physics, psychology, technology, and more from the world's leading research centers universities.

Febuxostat prevents gout flares in recent clinical trial

0

As reported in the journal Arthritis & Rheumatology, the drug febuxostat reduced gout flares in a double-blind, placebo-controlled study of 314 adults with early gout. Febuxostat treatment also reduced synovitis — or inflammation of the joint lining detected by MRI scanning — over a 2-year period compared with placebo.

Febuxostat treats high urate in the blood of patients with gout.

"Current clinical practice guidelines do not recommend routine use of urate-lowering therapy for people after the first gout flare. This study indicates that even for people who have had only 1 or 2 prior gout flares, urate-lowering therapy to reduce serum urate below 6mg/dL may have benefit in reducing future flares," said Dr. Nicola Dalbeth, lead author of the study.

###

Media Contact

Penny Smith
[email protected]

http://newsroom.wiley.com/

http://dx.doi.org/10.1002/art.40233

Leave A Reply

Your email address will not be published.